Aminoglycoside-induced ototoxicity

CMAJ

Volumn 187, Issue 1, 2015, Pages E52-

  Leis, Jerome A ^a,b   Rutka, John A ^c   Gold, Wayne L ^a  

^a GI Diseases Research Unit   (Canada)

^b Centre for Quality Improvement and Patient Safety   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMINOGLYCOSIDE;

ANTIBIOTIC THERAPY; ATAXIA; AUDIOMETRY; BALANCE IMPAIRMENT; DRUG MONITORING; DRUG WITHDRAWAL; EARDRUM PERFORATION; EARLY DIAGNOSIS; HEARING IMPAIRMENT; HUMAN; INFORMED CONSENT; INNER EAR DISEASE; NOTE; OSCILLOPSIA; OTOTOXICITY; PATIENT COUNSELING; QUALITY OF LIFE; TYMPANOSTOMY TUBE; VERTIGO; VESTIBULAR DISORDER; CHEMICALLY INDUCED; DRUG EFFECTS; HEARING DISORDER; PATIENT EDUCATION; RISK FACTOR; VESTIBULAR HAIR CELL;

AMINOGLYCOSIDES; HAIR CELLS, VESTIBULAR; HEARING DISORDERS; HUMANS; PATIENT EDUCATION AS TOPIC; RISK FACTORS; VESTIBULAR DISEASES;

EID: 84920612822     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.140339     Document Type: Note

References (6)

1. Ariano RE, Zelenit sky SA, Kassum DA. Aminoglycoside-induced vestibular injury: maintaining a sense of balance. Ann Pharmacother 2008; 42: 1282-9.
2. Black FO, Pesznecker S, Stallings V. Permanent gentamicin vestibulotoxicity. Otol Neurotol 2004; 25:559-69.
3. Marais J, Rutka JA. Ototoxicity and topical ear drops. Clin Otolaryngol 1998;23:360-7.
4. Zahar JR, Rio ux C, Girou E, et al. Inappropriate prescribing of aminoglycosides: risk factors and impact of an antibiotic control team. J Antimicrob Chemother 2006;58:651-6.
5. Berringer R. Aminoglycoside therapy : balancing risk versus benefit [R10814E]. Ottawa: Canadian Medical Protective Association; 2008. Available: https://oplfrpd5 .cmpa-Acpm.ca/-/aminoglycoside-therapy-balancing-risk-versus-benefit (accessed 2014 Aug. 22).
6. A hmed RM, Hannigan IP, MacDougall HG, et al. Gentamicin ototoxicity: a 23-year selected case series of 103 patients. Med J Aust 2012;196:701-4.